Drug Chatter -- Tracking biopharma stock chatter

Profile for Auris Medical Holding AG (EARS)

« Back to company index

EARS Chatter Timeline

Stock Ticker for EARS

Most Active Tweeters for EARS

UserTweets
@biostockinfo 9
@homdance 3
@ZolmaxNews 3
@stockboardinc 2
@Kevin_W81 2

Recent Tweets for EARS

emq_news @emq_news
Contrasting Auris Medical Holding AG $EARS & Paratek Pharmaceuticals $PRTK https://t.co/vHH1YLJhV6
September 23rd 2017, 8:09pm
TickerReport @TickerReport
Contrasting Auris Medical Holding AG $EARS & Paratek Pharmaceuticals $PRTK https://t.co/9MGwHkcN1P
September 23rd 2017, 8:09pm
intercooleronli @intercooleronli
Contrasting Auris Medical Holding AG $EARS & Paratek Pharmaceuticals $PRTK https://t.co/0v3HXJZrIm
September 23rd 2017, 8:09pm
CFinancialNews @CFinancialNews
Contrasting Auris Medical Holding AG $EARS & Paratek Pharmaceuticals $PRTK https://t.co/FghJ7OSjv9
September 23rd 2017, 8:09pm
TickerReport @TickerReport
Contrasting Auris Medical Holding AG $EARS & Paratek Pharmaceuticals $PRTK https://t.co/HKlwDUksSq
September 23rd 2017, 8:09pm
stockcharts247 @stockcharts247
EARS 0.810   -  Updated: 09-23-2017 $EARS Last Trade: 9/22/2017 Last 0.810   -  Open 0.750 Previous Cl https://t.co/FoYoICGNRE
September 23rd 2017, 10:09am
fm23 @fm23
$EARS https://t.co/OeC1bu5NWC
September 23rd 2017, 7:09am
VGaykin @VGaykin
$EARS v https://t.co/rEzVN90zP7
September 23rd 2017, 12:09am
dakotafinancial @dakotafinancial
Auris Medical Holding AG $EARS Sees Strong Trading Volume https://t.co/7bAr2KukcO
September 22nd 2017, 9:09pm
biostockinfo @biostockinfo
$ears strong close
September 22nd 2017, 4:09pm
MaisaCorp @MaisaCorp
$EARS completes patient recruitment for phase 3 TACTT3 trial of Keyzilen in acute and post-acute tinnitus = data in 1stQ2018
September 22nd 2017, 4:09pm
biostockinfo @biostockinfo
$ears +14%, volume
September 22nd 2017, 3:09pm
StockRanger_ @StockRanger_
In $EARS at .81
September 22nd 2017, 3:09pm
biostockinfo @biostockinfo
$ears +10%
September 22nd 2017, 3:09pm
homdance @homdance
$EARS flag alert
September 22nd 2017, 3:09pm
ErikDWater @ErikDWater
$EARS , PHASE 3 https://t.co/A1lVkZWXN4
September 22nd 2017, 2:09pm
homdance @homdance
$EARS here we go again
September 22nd 2017, 2:09pm
tgler @tgler
$EARS nice hits .80
September 22nd 2017, 2:09pm
AshleyDWater @AshleyDWater
$EARS going vertical , phase 3 , $0.79
September 22nd 2017, 2:09pm
NilsaM7 @NilsaM7
@DekmarTrades Thanks for $EARS!
September 22nd 2017, 2:09pm
RangerHolt @RangerHolt
Interesting $EARS volume the last 15 minutes. News?
September 22nd 2017, 2:09pm
homdance @homdance
$EARS here we go
September 22nd 2017, 2:09pm
GreenRoomForum @GreenRoomForum
$EARS blocks. Something's up.
September 22nd 2017, 2:09pm
GreenRoomForum @GreenRoomForum
$EARS ??
September 22nd 2017, 2:09pm
biostockinfo @biostockinfo
RT @odibro: $EARS Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute Tinnitus. Top line data 1Q 20…
September 22nd 2017, 1:09pm
StockNewsNow @StockNewsNow
$EARS Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute... https://t.co/c1LwG5O1s2
September 22nd 2017, 10:09am
russopartners @russopartners
$EARS Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute Tinnitus https://t.co/DGQH6l2HPU #health
September 22nd 2017, 10:09am
biostockinfo @biostockinfo
$ears top-line results from TACTT3 expected in first quarter 2018
September 22nd 2017, 10:09am
biostockinfo @biostockinfo
$ears https://t.co/0A8x2w1Tnd
September 22nd 2017, 10:09am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Auris Medical completes enrollment in late-stage study of Keyzilen tinnitus; shares up 3% https://t.co/FJPFz1rI6e $EARS
September 22nd 2017, 9:09am
MarketCurrents @MarketCurrents
Auris Medical completes enrollment in late-stage study of Keyzilen tinnitus; shares up 3% https://t.co/rN2hVA8OYL $EARS
September 22nd 2017, 9:09am
Onellymr @Onellymr
$EARS Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Po... https://t.co/MmbFR5ih8Z
September 22nd 2017, 8:09am
WizAtWallSt @WizAtWallSt
$EARS Completes patient recruitment for Phase III TACTT3 trial of Keyzilen in acute and post-acute tinnitus
September 22nd 2017, 8:09am
stockboardinc @stockboardinc
$EARS Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Pos... - https://t.co/Pw9dvUUC9A
September 22nd 2017, 8:09am
Al_the_Plumber @Al_the_Plumber
$EARS - Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and https://t.co/TEfJQlEudf
September 22nd 2017, 8:09am
GNWLive @GNWLive
Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute $EARS https://t.co/FtM4AjtdQC
September 22nd 2017, 8:09am
odibro @odibro
$EARS Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute Tinnitus. Top line data 1Q 2018
September 22nd 2017, 8:09am
4thQuarterCap @4thQuarterCap
Trimmed $EARS +12%
September 21st 2017, 7:09pm
StockNewsNow @StockNewsNow
$EARS Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27 https://t.co/myZGJS7KdG
September 20th 2017, 1:09pm
biostockinfo @biostockinfo
RT @stockboardinc: $EARS Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27... - https://t.co/…
September 20th 2017, 9:09am
StockTexts @StockTexts
$EARS Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27 Nasdaq:EARS https://t.co/WvqSU4IZIa
September 20th 2017, 8:09am
stockboardinc @stockboardinc
$EARS Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27... - https://t.co/8LBvi808iZ
September 20th 2017, 8:09am
Al_the_Plumber @Al_the_Plumber
$EARS - Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27 https://t.co/8ZsYF1jts2
September 20th 2017, 8:09am
GNWLive @GNWLive
Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27 $EARS https://t.co/hWDO5tVP0n
September 20th 2017, 8:09am
ZolmaxNews @ZolmaxNews
$EARS - Auris Medical Holding AG #EARS Given Daily Media Impact Score of 0.25 https://t.co/jsmLhZav9q
September 19th 2017, 9:09pm
SleekMoneycom @SleekMoneycom
Auris Medical Holding AG $EARS Given Daily Media Impact Score of 0.25 https://t.co/mowyhqqeux
September 19th 2017, 9:09pm
ZolmaxNews @ZolmaxNews
Auris Medical Holding AG $EARS Given Daily Media Impact Score of 0.25 https://t.co/VQdiTJEnu9
September 19th 2017, 9:09pm
noritsunagirota @noritsunagirota
Auris Medical Holding AG $EARS Forms $0.69 Double Bottom https://t.co/B84VVm7yNP
September 19th 2017, 9:09am
Kevin_W81 @Kevin_W81
@DoremonX7 @JSTOCKBROKERS i am scared. $EARS could increase stockholders equity to comply w Nasdaq rules. Deadline… https://t.co/LLrKXja9Gi
September 16th 2017, 3:09pm
Kevin_W81 @Kevin_W81
@DoremonX7 @JSTOCKBROKERS when are u guys buying $EARS. I want it under 0.65 and sell $0.95 8,000 shares
September 16th 2017, 2:09pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.